Department of Virology, Erasmus Medical Centre, University of Rotterdam, Rotterdam, The Netherlands.
J Med Virol. 2012 Oct;84(10):1680-96. doi: 10.1002/jmv.23354.
Viral infections are associated with coagulation disorders. All aspects of the coagulation cascade, primary hemostasis, coagulation, and fibrinolysis, can be affected. As a consequence, thrombosis and disseminated intravascular coagulation, hemorrhage, or both, may occur. Investigation of coagulation disorders as a consequence of different viral infections have not been performed uniformly. Common pathways are therefore not fully elucidated. In many severe viral infections there is no treatment other than supportive measures. A better understanding of the pathophysiology behind the association of viral infections and coagulation disorders is crucial for developing therapeutic strategies. This is of special importance in case of severe complications, such as those seen in hemorrhagic viral infections, the incidence of which is increasing worldwide. To date, only a few promising targets have been discovered, meaning the implementation in a clinical context is still hampered. This review discusses non-hemorrhagic and hemorrhagic viruses for which sufficient data on the association with hemostasis and related clinical features is available. This will enable clinicians to interpret research data and place them into a perspective.
病毒感染与凝血障碍有关。凝血级联的各个方面,包括初始止血、凝血和纤维蛋白溶解,都可能受到影响。因此,可能会发生血栓形成和弥散性血管内凝血、出血或两者兼有。针对不同病毒感染导致的凝血障碍的研究并未统一进行。因此,共同途径尚未完全阐明。在许多严重的病毒感染中,除了支持性治疗外,没有其他治疗方法。更好地了解病毒感染和凝血障碍之间的病理生理学关联对于制定治疗策略至关重要。在严重并发症的情况下尤其如此,例如在出血性病毒感染中所见的并发症,其发病率在全球范围内正在上升。迄今为止,仅发现了少数有希望的靶点,这意味着在临床环境中的实施仍然受到阻碍。本综述讨论了具有足够关于止血和相关临床特征的关联数据的非出血性和出血性病毒。这将使临床医生能够解释研究数据并将其置于适当的背景下。